Dermal Filler Under Eyes: What to Know Before Treatment

You've slept well, changed your concealer, and still hear some version of “You look tired.” In the mirror, the problem may not be exhaustion at all. A hollow beneath the lower eyelid can cast a shadow that makes the face look less rested, even when you feel fine.

Dermal filler under eyes, often called tear-trough filler, can soften that hollow when volume loss is the main issue. It isn't a universal fix for dark circles, bags, loose skin, or pigmentation, and the area deserves a more careful conversation than a routine filler appointment. The right decision depends on anatomy, product choice, placement, expectations, and the injector's ability to recognize and manage complications.

Table of Contents

What Under-Eye Filler Really Is and Why It Works

A person may notice a groove running from the inner corner of the eye toward the upper cheek. Concealer can brighten the surface, yet it cannot raise the depression beneath it. When the shadow reflects a genuine loss of support or volume, a carefully placed hyaluronic acid gel may soften the boundary between the lower eyelid and cheek.

Under-eye filler is usually placed in the tear trough or periorbital hollow. Hyaluronic acid, commonly abbreviated as HA, is a gel used to restore selected areas of volume. HA injections for tear-trough rejuvenation have been studied since the early 2000s. One review notes that this use began in 2005 and later became a mainstay of lower-eyelid rejuvenation. The clinical review of tear-trough rejuvenation describes the treatment as targeted placement rather than broad-volume filling.

A diagram explaining under-eye fillers, showing causes like aging and volume loss, and the treatment method.

The valley beneath the cheek

The cheek provides height beside a shallow valley that forms the tear trough. The lower eyelid sits above this contour, so changes in support from age or genetics can make the depression more visible and deepen its shadow.

Filler does not erase the eye area. It adds a small amount of support at a carefully selected depth, helping the lower eyelid meet the cheek more smoothly. The aim is softening a transition, not producing a puffy or overfilled appearance. That limited goal also explains why treatment planning matters more here than adding volume.

A prospective study cited in the clinical review found that 100% of patients reported overall improvement, while 75% were satisfied after the initial treatment. The remaining 25% needed additional filler to reach satisfaction. The study reported no major complications, although minor bruising and swelling lasted up to four weeks. Read the study details on hyaluronic acid tear-trough treatment.

Practical rule: Filler can improve a structural hollow and the shadow it creates. It won't reliably correct pigment, pronounced bags, significant laxity, or every cause of dark circles.

The distinction prevents a common misunderstanding. Darkness may come mainly from melanin, visible vessels, skin texture, or a bulging fat pad. In those situations, adding volume may leave the concern unchanged or make the area appear heavier. Assessment should identify the dominant cause before anyone discusses a syringe, and informed consent should also cover delayed complications and the rare possibility of vision-threatening vascular injury.

Anatomy of the Tear Trough and Why Hollows Form

The tear trough is shaped by several structures working together. The visible groove can reflect the relationship between the bone, fat pads, muscle, and skin, not merely a lack of filler beneath the eye.

The bony orbit provides the framework. Over time, changes in bony support can alter how the lower eyelid and cheek meet. Fat compartments can also shift or lose fullness, while the cheek fat pad may descend. The skin becomes thinner and less forgiving, allowing shadows and underlying structures to show more clearly. Genetics may create a noticeable groove early in life, even when age-related change is limited.

A deflated pillow analogy

Think of the cheek as a pillow supporting the edge of the lower eyelid. When the pillow is full and positioned well, the transition looks smooth. If it loses volume or slides downward, a crease can appear beside the eye. The skin covering that pillow may also become thinner, so the same underlying shape becomes easier to see.

This is why two people can use the same words, “I look tired,” and still need different plans. One person may have a true hollow with relatively good skin quality. Another may have thin, crepey skin that shows the filler itself. A third may have a prominent fat pad or malar fullness, where adding volume risks increasing heaviness.

An experienced injector assesses the contour at rest and during facial movement, the thickness of the skin, the cheek-to-lid transition, and the presence of puffiness. They also consider whether the hollow is mild, deep, sharply demarcated, or part of a broader midface pattern.

Matching the cause to the treatment

Filler makes the most sense when volume loss and shadowing are central. It may be less suitable when the main issue is surface pigmentation, pronounced skin laxity, or a true under-eye bag caused by fat protrusion. Mild concerns may call for a skin-quality approach rather than added volume.

ProMD Health Washington, DC's guidance on droopy eyelids can help readers distinguish eyelid-position concerns from a tear-trough hollow, although an in-person evaluation remains necessary for treatment planning.

A close-up of an anatomical model of a human face highlighting the muscular and fat layers.

The important question isn't “Do I have dark circles?” It's “What creates the appearance I want to change?” That answer determines whether filler belongs in the plan at all.

Filler Types, Technique, and the Needle vs Cannula Choice

Most tear-trough treatments use a hyaluronic acid filler selected for the delicate anatomy. In a Washington, DC consultation, an injector may discuss products from the Restylane, Juvederm, or RHA families when their characteristics fit the patient's skin, contour, and goals. The specific product matters, but placement matters just as much.

Thin under-eye skin can reveal problems that might be less visible elsewhere. A gel that attracts more water, sits too close to the surface, or is placed in excessive volume can contribute to swelling, contour irregularity, or a blue-gray cast known as the Tyndall effect. For that reason, experienced injectors generally favor a conservative plan with a soft, appropriate HA product.

Why depth and volume matter

A technical review recommends a maximum of 0.5 mL per eye at the supraperiosteal level, with placement methods that can include serial puncture, linear threading, or microbolus technique. The 2025 technical review of infraorbital filler emphasizes that the infraorbital region is prone to edema and contour irregularities when overfilled.

“More” isn't the definition of a successful correction. The goal is usually a small, deep placement that improves the contour without filling every visible line. The injector also needs to avoid the infraorbital foramen and nearby arterial branches while maintaining awareness of the vessels in the region.

Needle versus cannula

Patients often ask whether a cannula is automatically safer than a needle. The evidence doesn't support such a simple answer. A systematic review found no statistically significant difference between needle and cannula approaches in aesthetic results, satisfaction, or adverse-event incidence. Review the needle and cannula evidence.

A prospective comparative study found natural results with both techniques and less bruising with cannulas in that study, with no severe complications observed and no patients requiring hyaluronidase for overcorrection. See the comparative tear-trough study. Another observational study found that sharp-needle placement could disperse filler across multiple tissue layers, while an obliquely advanced cannula reached the periosteum more accurately, which the authors described as potentially safer. Read the anatomical placement comparison.

FactorNeedleCannula
BruisingAssociated with a higher incidence of ecchymosis in a meta-analysisMay produce less bruising in some comparative studies
SwellingCan be associated with less edema than cannula use in pooled dataAssociated with a higher incidence of edema in a meta-analysis
PlacementAllows precise puncture and controlled deliveryCan support a longer, oblique path through tissue
Overall resultCan produce natural correction in skilled handsCan produce natural correction in skilled hands

The pooled tradeoff is worth understanding. The meta-analysis of infraorbital HA injections found that needles were associated with significantly more ecchymosis, while cannulas were associated with significantly more edema. Ask which device the injector recommends for your anatomy, how they control volume, and whether dissolvable HA and emergency supplies are immediately available.

For product-specific planning, patients can review Restylane filler treatment in Washington, DC before discussing whether that family or another HA option fits their needs.

Who Is a Good Candidate and Who Should Wait

A strong candidate usually has a visible tear-trough hollow, enough skin thickness to conceal a deep placement, and realistic expectations. The best starting point is a structural concern that creates shadowing, rather than a promise to remove every sign of fatigue.

Signs that support candidacy

A consultation may be favorable when:

  • Volume is the main concern: The lower eyelid-to-cheek transition looks indented rather than puffy.
  • Skin has reasonable thickness: The tissue can support a subtle correction without making the gel visible.
  • The skin is calm: There's no active rash, infection, or inflammation in the treatment area.
  • Expectations are measured: You want a softer transition, not a permanently perfect lower eyelid.
  • Your history is clear: The injector knows about prior filler, eye procedures, allergies, medications, and relevant medical conditions.

A person with mild discoloration may still benefit if shadowing contributes to the appearance. But filler won't turn pigment into volume, and it won't necessarily improve loose, finely wrinkled skin.

Situations that call for caution

Thin, crepey skin deserves extra restraint because even a technically correct injection may show through or create an unnatural contour. Mild malar bags and persistent puffiness also require careful evaluation. These features can become more noticeable if the provider treats the hollow without accounting for the fullness beside it.

Treatment is commonly postponed during active inflammation, certain autoimmune flares, pregnancy, or recovery from recent eye surgery. Existing filler from another brand can also complicate planning when its location or composition is unclear and it can't be dissolved. The correct response isn't to force a treatment. It's to clarify the anatomy and wait when waiting improves safety.

A useful consultation question: “What part of my under-eye appearance is filler able to change, and what part needs another approach?”

Depending on the answer, a ProMD Health Washington, DC clinician may discuss a skin-quality treatment such as Skinvive, microneedling, a peel, or a laser-based option instead of, or before, filler. A pronounced bag or major laxity may belong in a surgical conversation rather than an injectable one.

An infographic showing the ideal candidates and those who should wait before getting under-eye dermal filler treatments.

The safest candidate isn't the person who wants the most correction. It's the person whose concern matches what the treatment can realistically address.

Real Risks, From Common Bruising to the Rare but Serious

A patient may look in the mirror a week after treatment, see that the bruising has faded, and assume the risk period has ended. Under-eye filler requires a longer view. Early swelling and bruising are common considerations, while some complications can appear months later and rare vascular events can threaten vision.

Bruising occurs in roughly 9% to 15% of tear-trough injections, while swelling occurs in roughly 2% to 20%. The same review of delayed and real-world tear-trough complications also identifies delayed reactions, so consent should cover both the first recovery period and later changes.

The late complications patients rarely hear about

A review of tear-trough filler found delayed swelling was the most common late complication at 42.3%, followed by lumps or nodules at 25.0%, xanthelasma-like reaction at 17.3%, migration at 7.7%, and discoloration at 3.0%. The average onset was 16.8 months. A result that looks settled after the first week therefore does not represent the full period in which a problem might appear.

These figures do not predict what will happen to one individual. They show why delayed symptoms belong in the consultation. Swelling months later may involve the product, fluid movement through the tissue, inflammation, allergy, infection, or changes in nearby anatomy. A nodule or contour change needs clinical examination. Repeated self-massage or adding more filler can make the situation harder to assess.

A clinician may monitor a mild finding, change the treatment plan, or use hyaluronidase when hyaluronic acid filler needs to be reduced. The appropriate response depends on the diagnosis, timing, location, and symptoms.

Rare ocular and vascular emergencies

The tear trough and infraorbital hollow contain arterial connections with the ophthalmic artery system. If filler enters a vessel, it can travel backward toward the central retinal circulation. The injection does not need to be placed inside the eye for vision loss to become possible. This anatomy-focused review of periocular filler complications explains why knowledge of vascular anatomy, careful depth selection, and avoidance of nearby vessels matter.

Reported severe outcomes include visual disturbance, central retinal artery occlusion, ischemic optic neuropathy, and stroke. In one review of filler-related vision-loss cases, hyaluronic acid accounted for 79.6% of cases. Immediate hyaluronidase near the injection site is discussed as part of emergency management, though urgent assessment is still required.

A later synthesis cited 198 reported patients with vision loss from cosmetic filler emboli, with 83% linked to hyaluronic acid fillers. The 2025 review of ophthalmological complications describes central retinal artery occlusion and ischemic optic neuropathy as potentially irreversible causes of vision loss.

The event is uncommon, yet its possible consequence changes what preparedness should look like. Before treatment, ask whether hyaluronidase is available on site, how the team identifies sudden visual symptoms, and which emergency pathway it follows.

Seek immediate help for sudden vision changes, severe eye pain, unusual weakness, difficulty speaking, or rapidly worsening skin color changes after injection. Do not wait for routine follow-up when a vascular emergency is possible.

An educational infographic outlining the common and rare risks associated with under-eye dermal filler treatments.

Safe care means discussing the ordinary recovery effects, the delayed complications, and the rare vision emergency before treatment. It also means selecting patients carefully, using conservative technique, and having a response plan if urgent treatment becomes necessary.

What the Appointment, Recovery, and Cost Actually Look Like

At ProMD Health Washington, DC, the process begins with a consultation at 1003 K Street NW. The clinician evaluates the hollow, skin quality, cheek fullness, prior procedures, and the difference between a shadow and a true pigment or bag concern.

The consultation is also the time to discuss whether an HA filler is appropriate, which product family may suit the area, and whether a conservative first treatment makes sense. The Entity Med AI Simulator can help patients preview a potential outcome before committing, but a simulation can't replace an examination of the tissue, vessels, and eye-area anatomy.

What happens on treatment day

A typical visit includes cleansing, planning, and an approach to comfort such as topical numbing when appropriate. The injection itself is brief, but the exact time depends on the assessment, device choice, placement plan, and whether one or both sides are treated.

The injector may place a small amount carefully, then pause to assess balance. You'll usually review the immediate appearance in a mirror, keeping in mind that early swelling can make the result look fuller than the settled outcome.

Recovery without false precision

The first 24 to 72 hours are often the most noticeable period for swelling or bruising. Swelling may be uneven, and one side can respond differently from the other. Mild effects may settle gradually, while final judgment should wait until the tissue has calmed.

For practical aftercare, patients are generally advised to:

  • Sleep with your head propped up: This may make early swelling easier to manage.
  • Pause strenuous exercise: Avoid intense activity for the period your clinician recommends, often 24 to 48 hours.
  • Protect the area from pressure: Don't rub, press, or massage unless the injector specifically instructs you to do so.
  • Use makeup cautiously: Wait for the short window advised by the clinic before applying products near the injection sites.
  • Report unexpected symptoms: Contact the clinic promptly if pain, discoloration, swelling, lumps, or vision changes seem unusual.

A clear explanation of the under-eye filler recovery time helps you plan work, social events, and photography without assuming that every person follows the same timeline.

Thinking about cost

Under-eye filler pricing varies with product selection, injector expertise, the amount used, and whether treatment is staged. A single syringe may be divided between both eyes in a conservative plan, while another patient may need a different amount or a later refinement. Rather than choosing by the lowest quoted price, ask what the fee includes, whether follow-up is part of the plan, and how the office handles unexpected concerns.

If you're considering dermal filler under eyes in Washington, DC, schedule a consultation with ProMD Health Washington, DC to review your anatomy, preview a potential result with the Entity Med AI Simulator, and determine whether a conservative filler plan or another facial rejuvenation option is appropriate.